Jasper Therapeutics, Inc. cotiza a 0.56 USD y tiene una capitalización bursátil de $18M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (…
| Periodo | 2026-11 | 2026-08 | 2026-08 | 2026-05 |
|---|---|---|---|---|
| Real | — | $-0.23 | — | $-0.38 |
| Estimado | $-0.56 | $-0.55 | $-0.55 | $-0.54 |
| Sorpresa | — | +58.2% | — | +29.6% |
| Métrica | JSPR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -1826.1% | -40.4% | -1785.7% |
| ROA | -211.9% | -32.0% | -179.9% |
| Current Ratio | 2.62 | 2.84 | -0.22 |
| Debt / Equity | — | 0.28 | — |